Oura Acquires Counsel Health for $625M: Wearables Move Into AI-Driven Primary Care

Oura Acquires Counsel Health for $625M: Wearables Move Into AI-Driven Primary Care

Oura’s Strategic Acquisition: Integrating AI for Personalized Healthcare

Oura is acquiring AI-native primary care startup Counsel Health for $625 million, signaling a move to combine its sleep and physiology wearable data with an owned AI and clinical platform. The deal positions Oura to build a care business that links continuous biometric signals to longitudinal primary care rather than relying on third party partnerships.

AI-Powered Care: Services and User Experience

Counsel Health provides AI tools that gather patient histories, surface relevant clinical guidelines, and summarize medical records to support physicians. Oura plans to offer an experience that pairs AI-driven triage and documentation with clinician oversight. The consumer pricing announced is $159 per year for access to AI consultations plus clinician visits with no insurance billing and no copay for visits. Patients may still pay separately for prescriptions, labs, or imaging. Counsel and Oura say privacy controls are available and services will roll out in limited geographies at first, which may restrict access while regulatory and clinical workflows are aligned.

Industry Impact: A New Era for Wearables in AI Healthcare

Owning the AI and clinical infrastructure gives Oura a pathway to convert passive sensor data into meaningful care actions and recurring revenue. This vertical integration aims to differentiate the company beyond hardware and membership features. Other wearable makers, including WHOOP, are pursuing clinician access and AI features, creating a broader trend of device manufacturers seeking to embed into care delivery. If executed well, this approach could streamline care coordination by linking device-generated alerts to care plans, but proof will depend on measurable clinical outcomes and cost impact.

The Road Ahead: AI Redefining Primary Care

This acquisition reads as a bellwether for AI-driven, remote, and personalized primary care. It highlights a shift toward companies controlling both data capture and the intelligence that interprets it. For clinicians, investors, and patients, the key questions will be how well integrated data improves decision making, how privacy and regulation are handled, and whether this model can demonstrably improve access, quality, and value in primary care.